Actualités Renovacor Inc - RCOR | Actions American Stock Exchange

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☒ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 ...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:December 05, 2022...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:December 05, 2022...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on December 1, 2022 Registration No. 333-263837 Registration No. 333-261054...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on December 1, 2022 Registration No. 333-263837 Registration No. 333-261054...

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on December 1, 2022. Registration No. 333-236977 Registration No. 333-260299...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER...

Robert W. Baird Keeps Their Hold Rating on Renovacor (RCOR)

Robert W. Baird analyst Jack Allen maintained a Hold rating on Renovacor (RCOR - Research Report) on November 14 and set a price target of $2.75...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement No. 13...

Quarterly Report (10-q)

falsethree years--12-31Q300017998500001799850us-gaap:MeasurementInputSharePriceMemberrcor:PrivatePlacementWarr...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...

Current Report Filing (8-k)

false 0001799850 0001799850 2022-10-14 2022-10-14 0001799850 rcor:CommonStockParValue0.0001PerShare2Member 2022-10-14 2022-10-14 0001799850...

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and...

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Renovacor Inc (RCOR)

Votre Hub pour des idées et discussions en direct en temps réel

Renovacor Inc (RCOR) Actualités

Statement of Changes in Beneficial Ownership (4)

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to Registration Statement (pos Am)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Robert W. Baird Keeps Their Hold Rating on Renovacor (RCOR)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Renovacor Inc (RCOR)

Votre Hub pour des idées et discussions en direct en temps réel

Renovacor Inc (RCOR) Actualités

Statement of Changes in Beneficial Ownership (4)

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to an S-8 Filing (s-8 Pos)

Post-effective Amendment to Registration Statement (pos Am)

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)

Robert W. Baird Keeps Their Hold Rating on Renovacor (RCOR)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités